VLA2001, a new COVID-19 vaccine developed by Valneva, a French biotechnology company, using traditional methods, has now received conditional marketing...
VLA2001, a new COVID-19 vaccine developed by Valneva, a French biotechnology company, using traditional methods, has now received conditional marketing...